Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01037_DB06684_nanopub.RAC0yw2z3rbwcBLpclv6EddT8BwxR2uv1apkaKo7YbHRg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01037_DB06684 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01037_DB06684 label "DDI between Selegiline and Vilazodone - MAO Inhibitors may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome. Avoid combination. [drugbank_resource:DB01037_DB06684]" assertion.
- drugbank_resource:DB01037_DB06684 identifier "drugbank_resource:DB01037_DB06684" assertion.
- drugbank_resource:DB01037_DB06684 title "DDI between Selegiline and Vilazodone - MAO Inhibitors may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome. Avoid combination." assertion.
- drugbank:DB01037 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01037_DB06684 assertion.
- drugbank:DB06684 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01037_DB06684 assertion.